LISTSERV mailing list manager LISTSERV 16.0

Help for PARKINSN Archives


PARKINSN Archives

PARKINSN Archives


PARKINSN@LISTSERV.UTORONTO.CA


View:

Message:

[

First

|

Previous

|

Next

|

Last

]

By Topic:

[

First

|

Previous

|

Next

|

Last

]

By Author:

[

First

|

Previous

|

Next

|

Last

]

Font:

Proportional Font

LISTSERV Archives

LISTSERV Archives

PARKINSN Home

PARKINSN Home

PARKINSN  February 1997, Week 5

PARKINSN February 1997, Week 5

Subject:

Help For Those Who Can't Afford The Meds

From:

John Cottingham <[log in to unmask]>

Reply-To:

Parkinson's Information Exchange <[log in to unmask]>

Date:

Fri, 28 Feb 1997 08:56:49 -0500

Content-Type:

text/plain

Parts/Attachments:

Parts/Attachments

text/plain (995 lines)

--=====================_857145541==_
Content-Type: text/plain; charset="us-ascii"


--=====================_857145541==_
Content-Type: text/plain; charset="us-ascii"


Subject: Help for those with PD who can't afford the Meds

I thought that I had previously posted this, couldn't find it in
the archive, so here it is.

Indigent Drugs
Prepared by the Staff of the Special Committee on Aging, United
States Senate, Senator David Pryor, Chairman
August 1994

This list was updated as of October 1994 by E. Loren Buhle, Jr.
Ph.D I recommend you use your SEARCHING tool in your word
processor to find either the drug or the pharmaceutical company.

The following drug companies have programs that will allow your
patients to receive free prescription drugs.

Each drug company offers about the same program. Some are a
little different. What it amounts to is either you, or the
patient call the representative I have listed and request
information on how to get signed up for their Indigent Patient
Program. The drug company will then send either you or the
patient the forms to fill out.

There are maybe 10 questions on each form. It is very simple.
You send the form back with a prescription for the drugs, in the
name of the patient, and they mail you back a three month supply.
Just pick up the phone and call the patient to come pick them
up at your office.


Adria Laboratories
Contact: Adria Laboratories Patient Assistance program
P.O.Box 9525
McLean VA 22102
Phone: 1-800366-5570

Drugs Available:
Adriamycin PFS
Adrucil
Folex
Idamycin
Neosar
Tarabine
Vincasar

Two months supply. Physician must certify patient is unable to
afford the cost of the drug, and is unable to obtain assistanc
elsewhere.


Allergan Prescription Pharmaceuticals
Contact: Judy McGee 1-800-347-4500 ext. 4280

Drugs Available:
Betagan
Bleph-10
Blephamide
FML
HMS
Oculinium
Pilogan
Propine
other OTC tear products

Course of therapy, up to a maximum of 6 months supply.
Eligibility criteria are at the physician's descretion.


Amgen, Inc.
Contact: Amgen Safety Net Programs
Medical Technology Hotlines: 1-800-272-9376 (202-637-6698 in
Washington, D.C.)

Drugs Available:
Epogen
Neupogen

Amgen's program consists of a universal patient program and a
variable cap prograam for uninsured patients. Enrollment in the
program is based on a patient's insurance and financial status.


Astra
Contact: F.A.I.R. (FOSCAVIR Assistance and Information on
Reimbursemebt)
1-800-488-3247


Foscavir (Foscarnet Sodium)

The physician must sign and  complete the application and return
it within seven days to the address indicated on the form. The
qualification form must also be accompanied by a signed
prescription.


Boehringer Ingleheim Parmaceuticals, Inc.
Contact: PARTNERS IN HEALTH
1-800-556-8317
Products Available:
Persantine
Atrovent
Alupent
Catapres

Controlled substances are not covered. Maximum of three months.
Patient cannot have prescription coverage, cannot be eligible
for Medicaid/State assistance programs, and must meet annual
income guidelines. Physician must initiate request.


Bristol Myers Squibb #1
(General Indigent Patient Program)
Contact: Bristol-Myers Indigent Patient Program
P.O. Box 9445
McLean, VA 22102-9998
1-800-736-0003
1-703-760-0049 (FAX)

Products Available:
Duricef
Cefzil
BuSpar
Desyrel
Estrace
Ovcon-35
Ovcon-50
Natalins
Natalins RX
Vagistat-1
Mycostatin

Three months' supply. Physician's request.


Bristol Myers Squibb #2
(Cardiovascular Access Program)
Contact: Bristol-Myers Cardiovascular Access Program
P.O. Box 9445
McLean, VA 22102-9998
1-800-736-0003
1-703-760-0049 (FAX)

Products Available:
Capoten
Capozide
Corgard
Corzide
Klotrix
K-Lyte
Monopril
Naturetin
Pravochol
Pronestyl-SR
Questran Light
Ranzide
Saluron
Salutensin
Vasodilan
Betapen-VK

Three months' supply. The patient must work through an enrolled
physician, cannot be eligible for any other sources of drug
coverage, such as Medicaid, or private insurance, and must be
deemed financially eligbile, as determined by "means" and
"liquid assets" tests.


Bristol Myers Squibb #3
Cancer Patient Access Program
Contact: Bristol-Myers Squibb
2400 West Lloynd Expressway
Evansville, IN 47721
Mail Code R-22
1-800-437-0994
Products Available:
BICNU
CEENU
Lysodren
Mutamycin
Mycostatin Pastilles
Paraplatin
Planitol
Planitol-AQ
VePesid
Blenoxance
Cytoxan
Lyophilized Cytoxan
Ifex
Mesnex
Megace

Two months' supply. Internal financial screening on a case-by-
case basis.


Burroughs-Wellcome
Contact Patient Information Services
Burroughs-Wellcome Co.
P.O. Box 52035
Phoenix AZ85072-9349
1-800-722-9294 (Program Enrollment)

Products Available:
Septra
Septra DS
Lanoxin
Mepron
AZT (Retrovir)
Zovirax
Zyloprim
Imuran
Wellcovorin

The products are available in a 30-day supply, with a maximum of
90 days therapy. Eligibility criteria that have to be met:
Gross monthly income must be less than 200% of Federal poverty
guidelines. All applications will be reviewed within establish
criteria and on a case-by-case basis. Patients must be residents
of the United States or territories. All alternative funding
sources must be investigated. All required information must be
provided for consideration of eligibility. Patients may be
approved (occasionally) by exception if extreme extenuating
circumstances exist.



Ciba-Geigy Pharmaceuticals
Contact: Jackie LaGuardia, Senior Information Assistant
Ciba-Geigy Corporation
556 Morris Ave, D2058
Summit, NJ 07091
1-800-257-3273
All the company's products (including those distributed by Basal
and Summit) are covered under the program, which include:
Lopressor Lotensin Lioresal Slow K Tegretol Voltaren
Brethine Estraderm Transderm Nitro

Ritalin and Rimactane are controlled substances and are not
covered. Up to a 3 months supply available.


Du Pont Merck
Contact: Darlene Samis
Du Pont Pharma
P.O. Box 80026
Wilmington, DE 19880-0026
1-800-474-2762
1-302-234-4327
Drugs Covered:
Coumadin
Lodosyn
Sinemet
Sinemet CR
Symmetrel
Trexan
Vaseretic

Controlled substances are not covered, which include Percodan and
Percocet. Thirty days' supply. The patient must be indigent and
ineligible for a Federal or State Government pharmaceutical
assistance program.

Genentech, Inc
Contact: Genentech Reimbursement Hotline
P.O. Box 2586
S. San Francisco, CA 94083-2586
1-800-530-3083
Products Available:
Protropin (Human Growth Hormone)
Activase (TPA, Tissue Plasminogen Activator)
Actimmune (Interferon Gamma-1b)
Nutropin
Pulmozyme

Quantity provided and eligibility requirements are variable.
Patients are asked to provide sufficiently detailed information
to assure the company that they are uninsured and cannot afford
the required payments. (For Activase: If an uninsured patient
has a gross family income of $25,000 or less, the company
provides replacement product to the hospital.)


Glaxo, Inc.
Contact: Laura N. Wright, Supervisor
Glaxco Indigent Patient Program
Glaxco, Inc.
P.O. Box 13438
Research Triangle Park
NC27709
1-800-452-9677
1-919-248-7971 (FAX)
Products Available:
Zantac
Ceftin
Ventolin
Beconase
Beconase AQ
Trandate
Maximum three months' supply. Patient must be a private
outpatient whom the physician considers medically indigent and
who is not eligible for any other third-party reimbursement.


Hoechst-Roussel, Pharmaceuticals, Inc.
Contact: Joyce Trotter, Field Forest Development
1-800-422-4779
Products Available:
Prokine (Sargramostim)
Lasix
Trental
Diabeta

Must show lack of insurance or ability to pay. The company
indicated that it provides other products to indigents upon
receipt of a prescription and a physician's letter certifying
that the patient is indigent. Eligibility is on a case-by-case
basis. This policy covers patients who are ineligible for a
third-party payer or Medicaid coverage. One course of therapy
(usually two to three weeks).


Hoffman-LaRouche, Inc.
Contact: Inge Shanahan
Medical Communications Associate
Roche Laboratories
340 Kingsland Street
Nutley, NJ 07110
1-800-526-6367
Teleprompter #2
201-235-2765 (FAX) They do not accept FAXed applications.
Products Available: All products are covered including
Valium
Librium
Limbritol
Dalmane
Hivid
Bactrim
Bactrim DS
Klonopin
Efudex (Fluorouracil Injectible)
Gantrisin
Gantanol
Interferon 2-A Recombinate
Rocephin Injectible
Rocaltrol

Three months' supply. Eligibility limited to private practice
outpatients who are considered by the physician to be medically
indigent and who are not eligible to receive Roche drugs through
any other third-party reimbursement program. The physician's
signature and DEA number are required for all applications,
whether or not the request is for a controlled prescription drug.
 Drugs are shipped to registered DEA addresses only.


Immunex Corporation
Contact: Professional Services Immunex Corporation
1-800-Immunex or 1-800-466-8639
206-587-0430
1-800-221-6820 (FAX)
Products Available:
Leukine 250 mcg
Leukine 500 mcg
Hydraea
Rubex

Three cycles. Physician must attest that the patient requires
the drug and that all the reimbursement options for the patient
have been tried.


Janssen Parmaceutica #1
Contact: Professional Services Department
Janssen Pharmaceutica Inc.
1125 Trenton-Harbourton Road
P.O. Box 200 Office A32000
Titusville, New Jersey 08560-0200
1-800-526-7736
Products Available:
Ergamisol (Levamisole HCL)
Hismanal
Alfenta
Sufenta
Sublimaze
Risperdal (1-800-652-6227)

Varies by product, patient condition. Physician determines that
patient is indigent and not eligible for health insurance.
Physicians may request free medications by written or telephone
requests, accompanied by a signed and dated prescription and
letter stating financial status and need of the patient.


Janssen Parmaceutica #2
Contact: Janssen Patient Assistance Program
1800 Robert Fulton Drive
Reston, VA 22091
1-800-544-2987
Products Available:
Ergamisol (Levamisole HCL)
Nizoral
Sporanox
Duragesic

One or two months supply, varies by product. Patient must have
less than $25,000 total annual household income and can have
Medicare or private insurance, but cannot have prescription
coverage.


Knoll Pharmaceuticals
Contact: Knoll Pharmaceuticals
Indigent Patient Program
30 N. Jefferson RD.
Whippany, N.J. 07981
1-800-524-2474
Drugs Available:
Isoptin
Rythmol
Santyl
Zostrix
Patients can enroll in the Heart-in Harmony program to receive
educational information. Contact the local company sales
representative, or call the patient help line.

Lederle Laboratories
Contact: Jerry Johnson, Pharm. D., Director
Induxtry Affairs
American Cyanamid, Inc.
One Cyanamid Plaza
Wayne, New Jersey 07470
1-800-533-2273
1-201-831-4484 (FAX)
Drugs Available:
Diamox
Artane
Mincoin
Leucovorin
Calcium Loxapine
Verelan
Rheumatrex
Maxzide
MyambutolPhysician has tomake the request. Patients have to be
financially indigent, and not eligible for coverage under third
party insurance or Medicaid reimbursement.

Eli Lilly, Inc.
Contact: Indigent Patient Program Administrator
Eli Lilly and Company
Patient Assistance Program
P.O. Box 9105
McLean, VA 22102-0105
1-800-545-6962
Products Available:
Ceclor
Keflex
Prozac
Dymelor
Axid
along with all insulin products such as Humulin and Iletin

This program does not cover controlled substances, which include
Darvon and Darvocet products. Quantities are dependent on the
product and the physician's instructions. Patient eligibility is
determined on a case-by-case basis in consultation with the
prescribing physician. Patients are not required to complete
enrollment forms. Physicians are asked to submit a written
request containing specific information.


Marion-Merrell Dow, Inc.
Contact: Indigent Patient Program
P.O. Box 8480
Kansas City, MO 64114
1-800-362-7466
Products Available:
Cardizem
Cardizem SR
Cardizem CD
Carafate
Pavabid
Seldane
Seldane-d
Nicorette
Rifidin
Quinamm
Lorelco
Three months' supply. The physician determines whether the
patient is eligible for the program.


McNeil Pharmaceutical
Contact: Thomas Schwend, Manager
Medical Information
McNeil Pharmaceutical Corporation
P.O. Box 300
Route 202 South
Raritan, NJ 08869-0602
902-218-6894Products Available:
Pancrease
Parafon Forte DSC
Haldol
Vascor
Tolectin
Varies by product, patient condition. Physician determines the
patient is indigent and not eligible for health insurance.
Physicians may request free medications by written or telephone
request, accompanied by a signed and dated prescription and
letter stating financial status and need of patient.

Merck, Sharp, and Dohme
Contact: Complimentary Products Program
Merck and Co., Inc.
P.O. Box 106634
Atlanta, GA 30348
1-800-637-2579

Products Available:
Mevacor
Plendil
Pepcid
Prilosec
Prinivil
Proscar
Timoptic
Timolol
Clinoril
Flexeril
Periactin
Noroxin
Cogentin
Indocin
Aldomet
Dolobid
Vasoretic
Vasotec
No injectibles. Requests for three months' supply are generally
honored. The patient's physician must:
provide awritten statement of medical needindicate the existence
of financial hardshipindicate the lack of patient eligibility for
prescription coverage from insurance or government assistance
programs Physician must also send a signed and dated written
prescription with doctor's DEA number.


Miles Pharmaceuticals
Contact: Professional Services
Attention: Miles Indigent Patient Program
400 Morgan Ave
West Haven, Connecticut 06516
1-203-937-2373
Products Available:
Cipro
Nimotop
Tridesilon Cream
Medication quantities and duration of support is determined on a
case-by-case basis. Physician must certify that the patient is
not eligible for or covered by government funded reimbursement
or insurance programs for medication. Patient's income must be
below federal poverty lines.


Ortho Biotechnology
Contact: Jacob Drapkin, Director
Health Care Systems
Ortho Biotech Financial Assistance Program
1800 Robert Fulton Drive
Reston, VA 22091
908-704-5074
908-526-4997 (FAX)
Assistance Program is for:
PROCRIT (Epoetin alfa)
LEUSTATIN (cladribine) Injectible
Program Criteria:
Financial Assistance Program (FAP) 1-800-447-3437 provides
PROCRIT therapy free of charge to any qualifying nondialysis
patient who cannot obtain insurance coverage, is uninsureed or
cannot afford the cost of their treatment. Cost Sharing Program
1-800-441-1366 limits the annual cost of PROCRIT expenditures
for a patient exceed approximately $8,500 for a calendar year,
regardless of third party coverage. LEUSTATIN Financial
Assistance Program 1-800-447-3437 provides LEUSTATIN therapy
free of charge toall persons who meet specific criteria and lack
financial resources and third-party insurance necessary to
obtain treatment.

Parke-Davis
Contact: Indigent Patient Program 201-540-2000
Products Available: All products except Centrax, those available
include: Dilantin Mandelamine Accupril Pyridium Nitrostat
Sublingual Tabrom Ponstel Procan Anusol HC Zarontin

All applications are taken over the phone. To apply, patient or
doctor calls Parke Davis with the following information:
Doctor's full name: address: phone number: Patient's
name:address:phone number:financial status:


Pfizer Pharmaceuticals, Inc #1
Contact: Mark Clark
Pfizer Indigent Patient Program
P.O. Box 25457
Alexandria, VA 22314
1-800-646-4455

Products Available:
Antivert
Marax
Diabinese
Cardura
Minizide
Navane
Sinequan
Zithromax
Feldene
Procardia
Procardia XL
Vibramycin
Vistril
Zoloft
Minipress
Minizide
Glucotrol

Up to three months' supply at one time, as prescribed by the
physician. Any patient that a physician is treating as indigent
is eligible. Patient must not be covered by third-party
insurance or Medicaid. Usually three to four weeks to receive
medication. Refills are available upon request by doctor.


Pfzier Inc, Program #2: Roerig Division
Contact: Diflucan Patient Assistance Program
1-800-869-9979
Product Covered:
Diflucan

Up to three months' supply at one time and then can reapply.
Patient must not have insurance or other third-party coverage.
Patient must not be eligible for a state AIDS drug assistance
program. Patient must have anincome of less than $25,000 a year
without dependents; or less than $40,000 a year with dependents.


Proctor & Gamble Pharmaceuticals, Inc
Contact: Customer Service
17 Eaton Avenue
Norwish, NY 13815
1-800-448-4878
1-607-335-2998 (FAX)
Products Available:
Asacol
Dantrium
Macrodantin
The quantity varies depending upon the situatin, but at least a
one month supply can be obtained upon receit of a physician's
prescription. The company relies on the physician's appraisal of
the patient need. The company also helps the patient identify
other sources of financial help to pay for the patient's
medications.

R&D Laboratories
R&D Laboratories, Inc.
4094 Glencoe Avenue
Marina del Ray, California 90292
1-800-338-9066
Every R&D Laboratories pharmaceutical nutritional supplement has
a special Indigent Patient Program sticker. Patients bring the
sticks from their bottles of R&D products with them when they
come to the dialysis unit. Stickers are attached to the back of
a booklet supplied by the company and the completed booklet is
returned to R&D Laboratories. For every 12 stickers we receive
from a unit, R&D sends nutritional product of facility's choice
for free distribution to indigent patients.


Sandoz Parmaceuticals, Inc.
Contact: Maria Hardin, Director
Sandoz Drug Cost Sharing Program
P.O. Box 8923
New Fairfield, CT 06812-1783
1-800-447-6673 (for all drugs)
1-800-937-6673 (for Clozaril)
The National Organization for Rare Disorders (NORD)/Sandoz Drug
Cost Share Program (DCSP) is solely administered by NORD.
Products available: Sandimmune Sandoglobulin Sandostatin
Parlodel Eldepryl Clozaril (under a separate program)

Patient is awarded up to one year's supply of drug, which is
shipped in three month supplies via the mail-order pharmacy
utilized by the program. Clozaril-Patient is eligible to receive
up to one year's supply of the drug, dispensed only one week at
a time, per dispensing requirements of package label. NORD
determines eligibility by medical and financial criteria, and
applies a cost share formula. The patient/applicant must
demonstrate financial need above and beyond the availability of
Federal and State funds, private insurance, or family resources.
NORD also determines patient eligibility for Clozaril program.

Sanofi Winthrop Pharm, Inc.
Contact: Sanofi Winthrop
Product Information Department
90 Park Avenue
New York, NY 10016
1-212-907-2000
1-800-446-6267 (Push #1 twice when automated answering machine
picks up Products Available: Aralen Danocrine Winstrol

One unit or one month supply, as requireed. Subject to
acceptance by the company, patients can obtain medications by
having their physician contact the company to request the
product, provide a written order for the product, and confirm
the patient's need.


Schering-Plough
Contact: For Intro/Eulexin Products:
Roger D. Graham Jr.
Marketing Manager
Oncology/Biotech
Service Program
Schering Laboratories
2000 Galloping Hill Road
Building K-5-2B2
Kenilworth, NJ 07033
For othe Schering products:
Drug Information Services Indigent Propgram
908-298-4000
1-800-526-4099

Products Available:
Inton-A - a supply for three months; renewals available for three
months at a time
Eulexin - Initial supply is for six months; renewals available
for six months at a time Trinalin Lotrimin Lotrisone
Diprosone Diprolene Fulvicin Proventil Vancenase Normodyne
Optimine

Where not specified, these drugs are provided for up to three
month; renewals available for three months at at time. Patient
eligibility is determined on a case-by-case basis, on inernal
criteria. The consutlation includes a review of the specific
case, as well as the availability of other means of health care
assistance.


G.D. Searle and Co.
Contact: "Patients in Need" Foundation
Searle Co.
P.O. Box 5110
Chicago, IL 60680
1-800-542-2526
1-708-470-6280 (FAX)
For general information abou the program:
Laura Leber, Associate Director
Public Affairs
1-708-470-6280

Products Available
Aldactazide
Aldactone
Calan
Calan Sr
Cytotec
Kerlone
Nitrodisc
Norpace
Norpace CR

Supply is based on the physician's assessment of the needs for
the patient. The program is conducted through the physician, who
determines the patient's eligibility based on medical and
economic need. Searle provides suggested guidelines to the
physician for determination of patient eligibility.


Sigma-Tau Parmaceuticals, Inc.
Contact: Michelle McCourt
Carnitor Drug Assistance Program, Administrator
National Organization for Rare Disease Disorders
P.O. Box 8923
New Fairfield, CT 06812-1783
1-800-999-6673 or 203-746-6518
1-203-746-6481 (FAX)
Product available:
Carnitor (Levocarnitine)

Three months' supply, up to one year. The patient must have no
other means for obtaining the drug through insurance or State or
Federal Assistance, or liquid assets, and cannot afford to
purchase the drug. Must be a U.S. citizen or permanent resident.


SmithKline Beecham: Program #1
Contact: SB Access to Care Program
SmithKline Beecham Pharmaceuticals
One Franklin Plaza FP-1320
Philadelphia, PA 19101
1-800-546-0420 (patient requests)
1-215-751-5749 (physician requests)
Products Available:
Tagamet
Augmentin
Relafen
Dyazide
Riduara
Bactroban
Compazine
Amoxil
Ridaura
all other SmithKline Beecham prescription products

Individual physicians determine which patients are eligible and
would benefit most from the Access to Care Program. Physicians
are required to submit forms to enroll patients in the program.
Three months' supply is available at one time. Requests must
originate from the physician.


Smithkline Beecham: Program #2
Contact: Eminase/Triostat Compassionate Care Programs
SmithKline Beecham Pharmaceuticals
One Franklin Plaza FP-1320
Philadelphia, PA 19101
1-800-866-6273
Products Available:
Eminase
Triostat

Patients must demonstrate ineligibility for other forms of
medical assistance and meet the program's income requirements
(single patients with annual incomes of $18,000 or less will be
eligible, andpersons who are married or have at least one
dependent will be eligible if their annual incomes are $25,000
or less). For each eligible patient, hospitals should submit a
Hospital Consent Form and an ApplicationForm with any one of the
following documents: a copy of the patient's medical record, a
pharmacy record, or the patient's bill.


Syntex Laboratories, Inc.
Contact: Cytovene Medical Information Line: 1-800-444-4200
General telephone number to inquire about indigent programs:
1-800-822-8255
Products Available:
Cytovene (anciclovir sodium) 500mg sterile powder
Naprosyn
Anaprox
Cardene
Synalar
Synemol
Ticlid
Toradol
Lidex
Nasalide

Up to 25 vials of Cytovene are available. Syntex provides
Cytovene free of charge when it is prescribed for an
immunocompromised patient who has been diagnosed as having
cytomegalovirus (CMV) retinitis, if that patient lacks the means
to purchase the drug, and that patient is ineligible for any
form of third-party reimbursement to pay for that drug.


Upjohn Company
Contact: Patient Consumer Information
Upjohn Company7000 Portage RdKalamazoo, MI 49001
616-323-6004
616-323-4551 (FAX)
Products Available:
Ansaid
Motrin
Provera
E-Mycin
Halcion
Xanax
Medrol
Cleocin
Lincocin
Loniten
Micronase
Orinase
Tolinase

Health Care Professionals should contact their local Upjohn
Representative. Generally, a three months' supply is provided.
However, a physician can request a supply for a longer period of
time. The physician deterines the patient's needs, and if
insurance or other social programs to help provide medications
are available.


Wyeth-Ayerst Laboratories #1
Contact: Wyeth-Ayerst Laboratories Indigent Patient Program
Roger J. Eurbin, Professional Services, IPP
P.O. Box 8299
Philadelphia, PA 19101
1-800-568-9938

All Product Covered:
Sectral
Cyclospasmol
Premarin
Isordil
Phenegran
Orudis
Wytensin
Cardarone
Birth Control Pills for Family Planning Clinics:
TriphasilLo/OvralNordette

In general, one or two months supply or the closes trade package
size available is provided. For Cordarone, one month supply or
up to two bottles of 60 tablets is provided. The number of
cycles of oral contraceptives given to the patient is determined
by a health care provider or the family planning clinic. The
patient must be medically indigent, with no form of coverage for
pharmaceutical products. The family planning clinic determines
eligibility for new and refill oral contraceptive cycles.

Wyeth-Ayerst Laboratories #2
Contact: Norplan Foundation
P.O. Box 25223
Alexandria, VA 22314
703-706-5933
Norplant (levonorgestrel implants)
Eligibility deteremined on a case-by-case basis and limited to
individuals who cannot afford the product and who are ineligible
for coverage under private and public sector programs.

Zeneca Pharmaceuticals
Contact: Yvonne A. Graham, Manager, Professional Services
Zeneca Pharmaceuticals Group
P.O. Box 15197
Wilmington, DE 19850-5197
1-800-424-3727
302-886-2231
Products Available:
Nolvadex
Zestoretic
Bucladin-S
Kinesed
Sorbitrate
Tenormin
Tenoretic
Zestril

One to three months supply with application.

These drugs are available usually just for the asking. Please
give your patient the best care and take the time to fill out
the form and mail it back to the drug company. It takes so
little time to do so and it will benefit the patient greatly.

You may order copies of this list free of charge by picking up
the phone and calling the Unisted States Senate, Department of
Aging: Majority: 202-224-5364 Minority: 202- 224-1467

This list was updated as of October 1994 by E. Loren Buhle, Jr.
Ph.D

John Cottingham         NEW ADDRESS:          [log in to unmask]
=================================================================


--=====================_857145541==_
Content-Type: text/plain; charset="us-ascii"

[log in to unmask]      That man may last, but never lives,
                        Who much receives, but nothing gives;
HomeBoy #Parkinsons         Whom none can love, whom none can thank,--
                               Creation's blot, creation's blank.
John Cottingham           Thomas Gibbons (1720-1785): When Jesus dwelt.











--=====================_857145541==_--

Top of Message | Previous Page | Permalink

Advanced Options


Options

Log In

Log In

Get Password

Get Password


Search Archives

Search Archives


Subscribe or Unsubscribe

Subscribe or Unsubscribe


Archives

March 2024, Week 4
January 2022, Week 4
November 2021, Week 4
February 2021, Week 2
December 2020, Week 2
October 2020, Week 4
June 2020, Week 4
May 2020, Week 2
May 2020, Week 1
April 2020, Week 5
April 2020, Week 1
March 2020, Week 5
March 2020, Week 4
March 2020, Week 2
March 2020, Week 1
February 2020, Week 4
February 2020, Week 3
February 2020, Week 1
January 2020, Week 5
January 2020, Week 2
October 2019, Week 1
September 2019, Week 5
September 2019, Week 3
July 2019, Week 1
June 2019, Week 5
June 2019, Week 4
June 2019, Week 3
June 2019, Week 1
April 2019, Week 5
April 2019, Week 4
April 2019, Week 2
March 2019, Week 5
March 2019, Week 3
March 2019, Week 2
March 2019, Week 1
February 2019, Week 4
January 2019, Week 3
January 2019, Week 2
January 2019, Week 1
December 2018, Week 5
December 2018, Week 4
December 2018, Week 2
November 2018, Week 3
November 2018, Week 2
November 2018, Week 1
October 2018, Week 4
October 2018, Week 3
October 2018, Week 1
September 2018, Week 4
September 2018, Week 3
August 2018, Week 4
August 2018, Week 3
August 2018, Week 1
July 2018, Week 4
July 2018, Week 3
July 2018, Week 2
July 2018, Week 1
June 2018, Week 5
June 2018, Week 3
June 2018, Week 1
May 2018, Week 5
May 2018, Week 4
May 2018, Week 3
May 2018, Week 2
May 2018, Week 1
April 2018, Week 4
April 2018, Week 3
April 2018, Week 2
February 2018, Week 3
January 2018, Week 5
January 2018, Week 2
January 2018, Week 1
December 2017, Week 4
December 2017, Week 3
December 2017, Week 1
November 2017, Week 5
November 2017, Week 4
November 2017, Week 3
November 2017, Week 2
November 2017, Week 1
October 2017, Week 4
October 2017, Week 2
October 2017, Week 1
September 2017, Week 5
September 2017, Week 4
September 2017, Week 3
September 2017, Week 2
September 2017, Week 1
August 2017, Week 4
August 2017, Week 2
August 2017, Week 1
July 2017, Week 5
July 2017, Week 4
July 2017, Week 3
July 2017, Week 2
July 2017, Week 1
June 2017, Week 5
June 2017, Week 4
June 2017, Week 3
June 2017, Week 2
June 2017, Week 1
May 2017, Week 5
May 2017, Week 4
May 2017, Week 3
May 2017, Week 2
May 2017, Week 1
April 2017, Week 3
April 2017, Week 2
April 2017, Week 1
March 2017, Week 4
March 2017, Week 3
March 2017, Week 2
March 2017, Week 1
February 2017, Week 3
February 2017, Week 2
February 2017, Week 1
January 2017, Week 4
January 2017, Week 2
January 2017, Week 1
December 2016, Week 5
December 2016, Week 4
December 2016, Week 2
December 2016, Week 1
November 2016, Week 4
November 2016, Week 3
November 2016, Week 2
November 2016, Week 1
October 2016, Week 4
October 2016, Week 3
October 2016, Week 1
September 2016, Week 3
September 2016, Week 2
September 2016, Week 1
August 2016, Week 4
July 2016, Week 5
July 2016, Week 4
July 2016, Week 3
July 2016, Week 2
July 2016, Week 1
June 2016, Week 5
June 2016, Week 3
June 2016, Week 2
June 2016, Week 1
May 2016, Week 5
May 2016, Week 4
May 2016, Week 3
May 2016, Week 2
May 2016, Week 1
April 2016, Week 5
April 2016, Week 4
April 2016, Week 3
April 2016, Week 2
April 2016, Week 1
March 2016, Week 5
March 2016, Week 4
March 2016, Week 3
March 2016, Week 2
March 2016, Week 1
February 2016, Week 5
February 2016, Week 4
February 2016, Week 3
February 2016, Week 2
February 2016, Week 1
January 2016, Week 5
January 2016, Week 4
January 2016, Week 3
January 2016, Week 2
January 2016, Week 1
December 2015, Week 5
December 2015, Week 4
December 2015, Week 3
December 2015, Week 2
December 2015, Week 1
November 2015, Week 5
November 2015, Week 3
November 2015, Week 2
November 2015, Week 1
October 2015, Week 5
October 2015, Week 4
October 2015, Week 3
October 2015, Week 2
October 2015, Week 1
September 2015, Week 5
September 2015, Week 4
September 2015, Week 3
September 2015, Week 2
September 2015, Week 1
August 2015, Week 5
August 2015, Week 4
August 2015, Week 3
August 2015, Week 2
August 2015, Week 1
July 2015, Week 5
July 2015, Week 4
July 2015, Week 3
July 2015, Week 2
July 2015, Week 1
June 2015, Week 5
June 2015, Week 4
June 2015, Week 3
June 2015, Week 2
June 2015, Week 1
May 2015, Week 5
May 2015, Week 4
May 2015, Week 3
May 2015, Week 2
May 2015, Week 1
April 2015, Week 4
April 2015, Week 3
April 2015, Week 2
April 2015, Week 1
March 2015, Week 5
March 2015, Week 4
March 2015, Week 3
March 2015, Week 2
March 2015, Week 1
February 2015, Week 4
February 2015, Week 3
February 2015, Week 2
February 2015, Week 1
January 2015, Week 5
January 2015, Week 4
January 2015, Week 3
January 2015, Week 2
December 2014, Week 5
December 2014, Week 4
December 2014, Week 3
December 2014, Week 2
December 2014, Week 1
November 2014, Week 5
November 2014, Week 4
November 2014, Week 3
November 2014, Week 2
November 2014, Week 1
October 2014, Week 5
October 2014, Week 4
October 2014, Week 3
October 2014, Week 2
October 2014, Week 1
September 2014, Week 5
September 2014, Week 4
September 2014, Week 3
September 2014, Week 2
September 2014, Week 1
August 2014, Week 5
August 2014, Week 4
August 2014, Week 3
August 2014, Week 2
August 2014, Week 1
July 2014, Week 5
July 2014, Week 4
July 2014, Week 3
July 2014, Week 2
July 2014, Week 1
June 2014, Week 5
June 2014, Week 4
June 2014, Week 3
June 2014, Week 2
June 2014, Week 1
May 2014, Week 4
May 2014, Week 3
May 2014, Week 2
May 2014, Week 1
April 2014, Week 5
April 2014, Week 4
April 2014, Week 3
April 2014, Week 2
April 2014, Week 1
March 2014, Week 5
March 2014, Week 4
March 2014, Week 3
March 2014, Week 2
March 2014, Week 1
February 2014, Week 4
February 2014, Week 3
February 2014, Week 2
February 2014, Week 1
January 2014, Week 5
January 2014, Week 4
January 2014, Week 3
January 2014, Week 2
January 2014, Week 1
December 2013, Week 5
December 2013, Week 4
December 2013, Week 3
December 2013, Week 2
December 2013, Week 1
November 2013, Week 4
November 2013, Week 3
November 2013, Week 2
November 2013, Week 1
October 2013, Week 5
October 2013, Week 4
October 2013, Week 3
October 2013, Week 2
October 2013, Week 1
September 2013, Week 5
September 2013, Week 4
September 2013, Week 3
September 2013, Week 2
September 2013, Week 1
August 2013, Week 5
August 2013, Week 4
August 2013, Week 3
August 2013, Week 2
August 2013, Week 1
July 2013, Week 5
July 2013, Week 4
July 2013, Week 3
July 2013, Week 2
July 2013, Week 1
June 2013, Week 5
June 2013, Week 4
June 2013, Week 3
June 2013, Week 2
June 2013, Week 1
May 2013, Week 5
May 2013, Week 4
May 2013, Week 3
May 2013, Week 2
May 2013, Week 1
April 2013, Week 5
April 2013, Week 4
April 2013, Week 3
April 2013, Week 2
April 2013, Week 1
March 2013, Week 5
March 2013, Week 4
March 2013, Week 3
March 2013, Week 2
March 2013, Week 1
February 2013, Week 4
February 2013, Week 3
February 2013, Week 2
February 2013, Week 1
January 2013, Week 5
January 2013, Week 3
January 2013, Week 2
January 2013, Week 1
December 2012, Week 5
December 2012, Week 4
December 2012, Week 3
December 2012, Week 2
December 2012, Week 1
November 2012, Week 5
November 2012, Week 3
November 2012, Week 2
November 2012, Week 1
October 2012, Week 5
October 2012, Week 4
October 2012, Week 3
October 2012, Week 2
October 2012, Week 1
September 2012, Week 5
September 2012, Week 4
September 2012, Week 3
September 2012, Week 2
September 2012, Week 1
August 2012, Week 5
August 2012, Week 4
August 2012, Week 3
August 2012, Week 2
August 2012, Week 1
July 2012, Week 5
July 2012, Week 4
July 2012, Week 3
July 2012, Week 2
July 2012, Week 1
June 2012, Week 5
June 2012, Week 4
June 2012, Week 3
June 2012, Week 2
June 2012, Week 1
May 2012, Week 5
May 2012, Week 4
May 2012, Week 3
May 2012, Week 2
May 2012, Week 1
April 2012, Week 5
April 2012, Week 4
April 2012, Week 3
April 2012, Week 2
April 2012, Week 1
March 2012, Week 5
March 2012, Week 4
March 2012, Week 3
March 2012, Week 2
March 2012, Week 1
February 2012, Week 5
February 2012, Week 4
February 2012, Week 3
February 2012, Week 2
February 2012, Week 1
January 2012, Week 5
January 2012, Week 4
January 2012, Week 3
January 2012, Week 2
January 2012, Week 1
December 2011, Week 5
December 2011, Week 4
December 2011, Week 3
December 2011, Week 2
December 2011, Week 1
November 2011, Week 5
November 2011, Week 4
November 2011, Week 3
November 2011, Week 2
November 2011, Week 1
October 2011, Week 5
October 2011, Week 4
October 2011, Week 3
October 2011, Week 2
October 2011, Week 1
September 2011, Week 5
September 2011, Week 4
September 2011, Week 3
September 2011, Week 2
September 2011, Week 1
August 2011, Week 5
August 2011, Week 4
August 2011, Week 3
August 2011, Week 2
August 2011, Week 1
July 2011, Week 5
July 2011, Week 4
July 2011, Week 3
July 2011, Week 2
July 2011, Week 1
June 2011, Week 5
June 2011, Week 4
June 2011, Week 3
June 2011, Week 2
June 2011, Week 1
May 2011, Week 5
May 2011, Week 4
May 2011, Week 3
May 2011, Week 2
May 2011, Week 1
April 2011, Week 5
April 2011, Week 4
April 2011, Week 3
April 2011, Week 2
April 2011, Week 1
March 2011, Week 5
March 2011, Week 4
March 2011, Week 3
March 2011, Week 2
March 2011, Week 1
February 2011, Week 4
February 2011, Week 3
February 2011, Week 2
February 2011, Week 1
January 2011, Week 5
January 2011, Week 4
January 2011, Week 3
January 2011, Week 2
January 2011, Week 1
December 2010, Week 5
December 2010, Week 4
December 2010, Week 3
December 2010, Week 2
December 2010, Week 1
November 2010, Week 5
November 2010, Week 4
November 2010, Week 3
November 2010, Week 2
November 2010, Week 1
October 2010, Week 5
October 2010, Week 4
October 2010, Week 3
October 2010, Week 2
October 2010, Week 1
September 2010, Week 5
September 2010, Week 4
September 2010, Week 3
September 2010, Week 2
September 2010, Week 1
August 2010, Week 5
August 2010, Week 4
August 2010, Week 3
August 2010, Week 2
August 2010, Week 1
July 2010, Week 5
July 2010, Week 4
July 2010, Week 3
July 2010, Week 2
July 2010, Week 1
June 2010, Week 5
June 2010, Week 4
June 2010, Week 3
June 2010, Week 2
June 2010, Week 1
May 2010, Week 5
May 2010, Week 4
May 2010, Week 3
May 2010, Week 2
May 2010, Week 1
April 2010, Week 5
April 2010, Week 4
April 2010, Week 3
April 2010, Week 2
April 2010, Week 1
March 2010, Week 5
March 2010, Week 4
March 2010, Week 3
March 2010, Week 2
March 2010, Week 1
February 2010, Week 4
February 2010, Week 3
February 2010, Week 2
February 2010, Week 1
January 2010, Week 5
January 2010, Week 4
January 2010, Week 3
January 2010, Week 2
January 2010, Week 1
December 2009, Week 5
December 2009, Week 4
December 2009, Week 3
December 2009, Week 2
December 2009, Week 1
November 2009, Week 5
November 2009, Week 4
November 2009, Week 3
November 2009, Week 2
November 2009, Week 1
October 2009, Week 5
October 2009, Week 4
October 2009, Week 3
October 2009, Week 2
October 2009, Week 1
September 2009, Week 5
September 2009, Week 4
September 2009, Week 3
September 2009, Week 2
September 2009, Week 1
August 2009, Week 5
August 2009, Week 4
August 2009, Week 3
August 2009, Week 2
August 2009, Week 1
July 2009, Week 5
July 2009, Week 4
July 2009, Week 3
July 2009, Week 2
July 2009, Week 1
June 2009, Week 5
June 2009, Week 4
June 2009, Week 3
June 2009, Week 2
June 2009, Week 1
May 2009, Week 5
May 2009, Week 4
May 2009, Week 3
May 2009, Week 2
May 2009, Week 1
April 2009, Week 5
April 2009, Week 4
April 2009, Week 3
April 2009, Week 2
April 2009, Week 1
March 2009, Week 5
March 2009, Week 4
March 2009, Week 3
March 2009, Week 2
March 2009, Week 1
February 2009, Week 4
February 2009, Week 3
February 2009, Week 2
February 2009, Week 1
January 2009, Week 5
January 2009, Week 4
January 2009, Week 3
January 2009, Week 2
January 2009, Week 1
December 2008, Week 5
December 2008, Week 4
December 2008, Week 3
December 2008, Week 2
December 2008, Week 1
November 2008, Week 5
November 2008, Week 4
November 2008, Week 3
November 2008, Week 2
November 2008, Week 1
October 2008, Week 5
October 2008, Week 4
October 2008, Week 3
October 2008, Week 2
October 2008, Week 1
September 2008, Week 5
September 2008, Week 4
September 2008, Week 3
September 2008, Week 2
September 2008, Week 1
August 2008, Week 5
August 2008, Week 4
August 2008, Week 3
August 2008, Week 2
August 2008, Week 1
July 2008, Week 5
July 2008, Week 4
July 2008, Week 3
July 2008, Week 2
July 2008, Week 1
June 2008, Week 5
June 2008, Week 4
June 2008, Week 3
June 2008, Week 2
June 2008, Week 1
May 2008, Week 5
May 2008, Week 4
May 2008, Week 3
May 2008, Week 2
May 2008, Week 1
April 2008, Week 5
April 2008, Week 4
April 2008, Week 3
April 2008, Week 2
April 2008, Week 1
March 2008, Week 5
March 2008, Week 4
March 2008, Week 3
March 2008, Week 2
March 2008, Week 1
February 2008, Week 5
February 2008, Week 4
February 2008, Week 3
February 2008, Week 2
February 2008, Week 1
January 2008, Week 5
January 2008, Week 4
January 2008, Week 3
January 2008, Week 2
January 2008, Week 1
December 2007, Week 5
December 2007, Week 4
December 2007, Week 3
December 2007, Week 2
December 2007, Week 1
November 2007, Week 5
November 2007, Week 4
November 2007, Week 3
November 2007, Week 2
November 2007, Week 1
October 2007, Week 5
October 2007, Week 4
October 2007, Week 3
October 2007, Week 2
October 2007, Week 1
September 2007, Week 5
September 2007, Week 4
September 2007, Week 3
September 2007, Week 2
September 2007, Week 1
August 2007, Week 5
August 2007, Week 4
August 2007, Week 3
August 2007, Week 2
August 2007, Week 1
July 2007, Week 5
July 2007, Week 4
July 2007, Week 3
July 2007, Week 2
July 2007, Week 1
June 2007, Week 5
June 2007, Week 4
June 2007, Week 3
June 2007, Week 2
June 2007, Week 1
May 2007, Week 5
May 2007, Week 4
May 2007, Week 3
May 2007, Week 2
May 2007, Week 1
April 2007, Week 5
April 2007, Week 4
April 2007, Week 3
April 2007, Week 2
April 2007, Week 1
March 2007, Week 5
March 2007, Week 4
March 2007, Week 3
March 2007, Week 2
March 2007, Week 1
February 2007, Week 4
February 2007, Week 3
February 2007, Week 2
February 2007, Week 1
January 2007, Week 5
January 2007, Week 4
January 2007, Week 3
January 2007, Week 2
January 2007, Week 1
December 2006, Week 5
December 2006, Week 4
December 2006, Week 3
December 2006, Week 2
December 2006, Week 1
November 2006, Week 5
November 2006, Week 4
November 2006, Week 3
November 2006, Week 2
November 2006, Week 1
October 2006, Week 5
October 2006, Week 4
October 2006, Week 3
October 2006, Week 2
October 2006, Week 1
September 2006, Week 5
September 2006, Week 4
September 2006, Week 3
September 2006, Week 2
September 2006, Week 1
August 2006, Week 5
August 2006, Week 4
August 2006, Week 3
August 2006, Week 2
August 2006, Week 1
July 2006, Week 5
July 2006, Week 4
July 2006, Week 3
July 2006, Week 2
July 2006, Week 1
June 2006, Week 5
June 2006, Week 4
June 2006, Week 3
June 2006, Week 2
June 2006, Week 1
May 2006, Week 5
May 2006, Week 4
May 2006, Week 3
May 2006, Week 2
May 2006, Week 1
April 2006, Week 5
April 2006, Week 4
April 2006, Week 3
April 2006, Week 2
April 2006, Week 1
March 2006, Week 5
March 2006, Week 4
March 2006, Week 3
March 2006, Week 2
March 2006, Week 1
February 2006, Week 4
February 2006, Week 3
February 2006, Week 2
February 2006, Week 1
January 2006, Week 5
January 2006, Week 4
January 2006, Week 3
January 2006, Week 2
January 2006, Week 1
December 2005, Week 5
December 2005, Week 4
December 2005, Week 3
December 2005, Week 2
December 2005, Week 1
November 2005, Week 5
November 2005, Week 4
November 2005, Week 3
November 2005, Week 2
November 2005, Week 1
October 2005, Week 5
October 2005, Week 4
October 2005, Week 3
October 2005, Week 2
October 2005, Week 1
September 2005, Week 5
September 2005, Week 4
September 2005, Week 3
September 2005, Week 2
September 2005, Week 1
August 2005, Week 5
August 2005, Week 4
August 2005, Week 3
August 2005, Week 2
August 2005, Week 1
July 2005, Week 5
July 2005, Week 4
July 2005, Week 3
July 2005, Week 2
July 2005, Week 1
June 2005, Week 5
June 2005, Week 4
June 2005, Week 3
June 2005, Week 2
June 2005, Week 1
May 2005, Week 5
May 2005, Week 4
May 2005, Week 3
May 2005, Week 2
May 2005, Week 1
April 2005, Week 5
April 2005, Week 4
April 2005, Week 3
April 2005, Week 2
April 2005, Week 1
March 2005, Week 5
March 2005, Week 4
March 2005, Week 3
March 2005, Week 2
March 2005, Week 1
February 2005, Week 4
February 2005, Week 3
February 2005, Week 2
February 2005, Week 1
January 2005, Week 5
January 2005, Week 4
January 2005, Week 3
January 2005, Week 2
January 2005, Week 1
December 2004, Week 5
December 2004, Week 4
December 2004, Week 3
December 2004, Week 2
December 2004, Week 1
November 2004, Week 5
November 2004, Week 4
November 2004, Week 3
November 2004, Week 2
November 2004, Week 1
October 2004, Week 5
October 2004, Week 4
October 2004, Week 3
October 2004, Week 2
October 2004, Week 1
September 2004, Week 5
September 2004, Week 4
September 2004, Week 3
September 2004, Week 2
September 2004, Week 1
August 2004, Week 5
August 2004, Week 4
August 2004, Week 3
August 2004, Week 2
August 2004, Week 1
July 2004, Week 5
July 2004, Week 4
July 2004, Week 3
July 2004, Week 2
July 2004, Week 1
June 2004, Week 5
June 2004, Week 4
June 2004, Week 3
June 2004, Week 2
June 2004, Week 1
May 2004, Week 5
May 2004, Week 4
May 2004, Week 3
May 2004, Week 2
May 2004, Week 1
April 2004, Week 5
April 2004, Week 4
April 2004, Week 3
April 2004, Week 2
April 2004, Week 1
March 2004, Week 5
March 2004, Week 4
March 2004, Week 3
March 2004, Week 2
March 2004, Week 1
February 2004, Week 5
February 2004, Week 4
February 2004, Week 3
February 2004, Week 2
February 2004, Week 1
January 2004, Week 5
January 2004, Week 4
January 2004, Week 3
January 2004, Week 2
January 2004, Week 1
December 2003, Week 5
December 2003, Week 4
December 2003, Week 3
December 2003, Week 2
December 2003, Week 1
November 2003, Week 5
November 2003, Week 4
November 2003, Week 3
November 2003, Week 2
November 2003, Week 1
October 2003, Week 5
October 2003, Week 4
October 2003, Week 3
October 2003, Week 2
October 2003, Week 1
September 2003, Week 5
September 2003, Week 4
September 2003, Week 3
September 2003, Week 2
September 2003, Week 1
August 2003, Week 5
August 2003, Week 4
August 2003, Week 3
August 2003, Week 2
August 2003, Week 1
July 2003, Week 5
July 2003, Week 4
July 2003, Week 3
July 2003, Week 2
July 2003, Week 1
June 2003, Week 5
June 2003, Week 4
June 2003, Week 3
June 2003, Week 2
June 2003, Week 1
May 2003, Week 5
May 2003, Week 4
May 2003, Week 3
May 2003, Week 2
May 2003, Week 1
April 2003, Week 5
April 2003, Week 4
April 2003, Week 3
April 2003, Week 2
April 2003, Week 1
March 2003, Week 5
March 2003, Week 4
March 2003, Week 3
March 2003, Week 2
March 2003, Week 1
February 2003, Week 4
February 2003, Week 3
February 2003, Week 2
February 2003, Week 1
January 2003, Week 5
January 2003, Week 4
January 2003, Week 3
January 2003, Week 2
January 2003, Week 1
December 2002, Week 5
December 2002, Week 4
December 2002, Week 3
December 2002, Week 2
December 2002, Week 1
November 2002, Week 5
November 2002, Week 4
November 2002, Week 3
November 2002, Week 2
November 2002, Week 1
October 2002, Week 5
October 2002, Week 4
October 2002, Week 3
October 2002, Week 2
October 2002, Week 1
September 2002, Week 5
September 2002, Week 4
September 2002, Week 3
September 2002, Week 2
September 2002, Week 1
August 2002, Week 5
August 2002, Week 4
August 2002, Week 3
August 2002, Week 2
August 2002, Week 1
July 2002, Week 5
July 2002, Week 4
July 2002, Week 3
July 2002, Week 2
July 2002, Week 1
June 2002, Week 5
June 2002, Week 4
June 2002, Week 3
June 2002, Week 2
June 2002, Week 1
May 2002, Week 5
May 2002, Week 4
May 2002, Week 3
May 2002, Week 2
May 2002, Week 1
April 2002, Week 5
April 2002, Week 4
April 2002, Week 3
April 2002, Week 2
April 2002, Week 1
March 2002, Week 5
March 2002, Week 4
March 2002, Week 3
March 2002, Week 2
March 2002, Week 1
February 2002, Week 4
February 2002, Week 3
February 2002, Week 2
February 2002, Week 1
January 2002, Week 5
January 2002, Week 4
January 2002, Week 3
January 2002, Week 2
January 2002, Week 1
December 2001, Week 5
December 2001, Week 4
December 2001, Week 3
December 2001, Week 2
December 2001, Week 1
November 2001, Week 5
November 2001, Week 4
November 2001, Week 3
November 2001, Week 2
November 2001, Week 1
October 2001, Week 5
October 2001, Week 4
October 2001, Week 3
October 2001, Week 2
October 2001, Week 1
September 2001, Week 5
September 2001, Week 4
September 2001, Week 3
September 2001, Week 2
September 2001, Week 1
August 2001, Week 5
August 2001, Week 4
August 2001, Week 3
August 2001, Week 2
August 2001, Week 1
July 2001, Week 5
July 2001, Week 4
July 2001, Week 3
July 2001, Week 2
July 2001, Week 1
June 2001, Week 5
June 2001, Week 4
June 2001, Week 3
June 2001, Week 2
June 2001, Week 1
May 2001, Week 5
May 2001, Week 4
May 2001, Week 3
May 2001, Week 2
May 2001, Week 1
April 2001, Week 5
April 2001, Week 4
April 2001, Week 3
April 2001, Week 2
April 2001, Week 1
March 2001, Week 5
March 2001, Week 4
March 2001, Week 3
March 2001, Week 2
March 2001, Week 1
February 2001, Week 4
February 2001, Week 3
February 2001, Week 2
February 2001, Week 1
January 2001, Week 5
January 2001, Week 4
January 2001, Week 3
January 2001, Week 2
January 2001, Week 1
December 2000, Week 5
December 2000, Week 4
December 2000, Week 3
December 2000, Week 2
December 2000, Week 1
November 2000, Week 5
November 2000, Week 4
November 2000, Week 3
November 2000, Week 2
November 2000, Week 1
October 2000, Week 5
October 2000, Week 4
October 2000, Week 3
October 2000, Week 2
October 2000, Week 1
September 2000, Week 5
September 2000, Week 4
September 2000, Week 3
September 2000, Week 2
September 2000, Week 1
August 2000, Week 5
August 2000, Week 4
August 2000, Week 3
August 2000, Week 2
August 2000, Week 1
July 2000, Week 5
July 2000, Week 4
July 2000, Week 3
July 2000, Week 2
July 2000, Week 1
June 2000, Week 5
June 2000, Week 4
June 2000, Week 3
June 2000, Week 2
June 2000, Week 1
May 2000, Week 5
May 2000, Week 4
May 2000, Week 3
May 2000, Week 2
May 2000, Week 1
April 2000, Week 5
April 2000, Week 4
April 2000, Week 3
April 2000, Week 2
April 2000, Week 1
March 2000, Week 5
March 2000, Week 4
March 2000, Week 3
March 2000, Week 2
March 2000, Week 1
February 2000, Week 5
February 2000, Week 4
February 2000, Week 3
February 2000, Week 2
February 2000, Week 1
January 2000, Week 5
January 2000, Week 4
January 2000, Week 3
January 2000, Week 2
January 2000, Week 1
December 1999, Week 5
December 1999, Week 4
December 1999, Week 3
December 1999, Week 2
December 1999, Week 1
November 1999, Week 5
November 1999, Week 4
November 1999, Week 3
November 1999, Week 2
November 1999, Week 1
October 1999, Week 5
October 1999, Week 4
October 1999, Week 3
October 1999, Week 2
October 1999, Week 1
September 1999, Week 5
September 1999, Week 4
September 1999, Week 3
September 1999, Week 2
September 1999, Week 1
August 1999, Week 5
August 1999, Week 4
August 1999, Week 3
August 1999, Week 2
August 1999, Week 1
July 1999, Week 5
July 1999, Week 4
July 1999, Week 3
July 1999, Week 2
July 1999, Week 1
June 1999, Week 5
June 1999, Week 4
June 1999, Week 3
June 1999, Week 2
June 1999, Week 1
May 1999, Week 5
May 1999, Week 4
May 1999, Week 3
May 1999, Week 2
May 1999, Week 1
April 1999, Week 5
April 1999, Week 4
April 1999, Week 3
April 1999, Week 2
April 1999, Week 1
March 1999, Week 5
March 1999, Week 4
March 1999, Week 3
March 1999, Week 2
March 1999, Week 1
February 1999, Week 4
February 1999, Week 3
February 1999, Week 2
February 1999, Week 1
January 1999, Week 5
January 1999, Week 4
January 1999, Week 3
January 1999, Week 2
January 1999, Week 1
December 1998, Week 5
December 1998, Week 4
December 1998, Week 3
December 1998, Week 2
December 1998, Week 1
November 1998, Week 5
November 1998, Week 4
November 1998, Week 3
November 1998, Week 2
November 1998, Week 1
October 1998, Week 5
October 1998, Week 4
October 1998, Week 3
October 1998, Week 2
October 1998, Week 1
September 1998, Week 5
September 1998, Week 4
September 1998, Week 3
September 1998, Week 2
September 1998, Week 1
August 1998, Week 5
August 1998, Week 4
August 1998, Week 3
August 1998, Week 2
August 1998, Week 1
July 1998, Week 5
July 1998, Week 4
July 1998, Week 3
July 1998, Week 2
July 1998, Week 1
June 1998, Week 5
June 1998, Week 4
June 1998, Week 3
June 1998, Week 2
June 1998, Week 1
May 1998, Week 5
May 1998, Week 4
May 1998, Week 3
May 1998, Week 2
May 1998, Week 1
April 1998, Week 5
April 1998, Week 4
April 1998, Week 3
April 1998, Week 2
April 1998, Week 1
March 1998, Week 5
March 1998, Week 4
March 1998, Week 3
March 1998, Week 2
March 1998, Week 1
February 1998, Week 5
February 1998, Week 4
February 1998, Week 3
February 1998, Week 2
February 1998, Week 1
January 1998, Week 5
January 1998, Week 4
January 1998, Week 3
January 1998, Week 2
January 1998, Week 1
December 1997, Week 5
December 1997, Week 4
December 1997, Week 3
December 1997, Week 2
December 1997, Week 1
November 1997, Week 5
November 1997, Week 4
November 1997, Week 3
November 1997, Week 2
November 1997, Week 1
October 1997, Week 5
October 1997, Week 4
October 1997, Week 3
October 1997, Week 2
October 1997, Week 1
September 1997, Week 5
September 1997, Week 4
September 1997, Week 3
September 1997, Week 2
September 1997, Week 1
August 1997, Week 5
August 1997, Week 4
August 1997, Week 3
August 1997, Week 2
August 1997, Week 1
July 1997, Week 5
July 1997, Week 4
July 1997, Week 3
July 1997, Week 2
July 1997, Week 1
June 1997, Week 5
June 1997, Week 4
June 1997, Week 3
June 1997, Week 2
June 1997, Week 1
May 1997, Week 5
May 1997, Week 4
May 1997, Week 3
May 1997, Week 2
May 1997, Week 1
April 1997, Week 5
April 1997, Week 4
April 1997, Week 3
April 1997, Week 2
April 1997, Week 1
March 1997, Week 5
March 1997, Week 4
March 1997, Week 3
March 1997, Week 2
March 1997, Week 1
February 1997, Week 5
February 1997, Week 4
February 1997, Week 3
February 1997, Week 2
February 1997, Week 1
January 1997, Week 5
January 1997, Week 4
January 1997, Week 3
January 1997, Week 2
January 1997, Week 1
December 1996, Week 5
December 1996, Week 4
December 1996, Week 3
December 1996, Week 2
December 1996, Week 1
November 1996, Week 5
November 1996, Week 4
November 1996, Week 3
November 1996, Week 2
November 1996, Week 1
October 1996, Week 5
October 1996, Week 4
October 1996, Week 3
October 1996, Week 2
October 1996, Week 1
September 1996, Week 5
September 1996, Week 4
September 1996, Week 3
September 1996, Week 2
September 1996, Week 1
August 1996, Week 5
August 1996, Week 4
August 1996, Week 3
August 1996, Week 2
August 1996, Week 1
July 1996, Week 5
July 1996, Week 4
July 1996, Week 3
July 1996, Week 2
July 1996, Week 1
June 1996, Week 5
June 1996, Week 4
June 1996, Week 3
June 1996, Week 2
June 1996, Week 1
May 1996, Week 5
May 1996, Week 4
May 1996, Week 3
May 1996, Week 2
May 1996, Week 1
April 1996, Week 5
April 1996, Week 4
April 1996, Week 3
April 1996, Week 2
April 1996, Week 1
March 1996, Week 5
March 1996, Week 4
March 1996, Week 3
March 1996, Week 2
March 1996, Week 1
February 1996, Week 5
February 1996, Week 4
February 1996, Week 3
February 1996, Week 2
February 1996, Week 1
January 1996, Week 5
January 1996, Week 4
January 1996, Week 3
January 1996, Week 2
January 1996, Week 1
December 1995, Week 5
December 1995, Week 4
December 1995, Week 3
December 1995, Week 2
December 1995, Week 1
November 1995, Week 5
November 1995, Week 4
November 1995, Week 3
November 1995, Week 2
November 1995, Week 1
October 1995, Week 5
October 1995, Week 4
October 1995, Week 3
October 1995, Week 2
October 1995, Week 1
September 1995, Week 5
September 1995, Week 4
September 1995, Week 3
September 1995, Week 2
September 1995, Week 1
August 1995, Week 5
August 1995, Week 4
August 1995, Week 3
August 1995, Week 2
August 1995, Week 1
July 1995, Week 5
July 1995, Week 4
July 1995, Week 3
July 1995, Week 2
July 1995, Week 1
June 1995, Week 5
June 1995, Week 4
June 1995, Week 3
June 1995, Week 2
June 1995, Week 1
May 1995, Week 5
May 1995, Week 4
May 1995, Week 3
May 1995, Week 2
May 1995, Week 1
April 1995, Week 5
April 1995, Week 4
April 1995, Week 3
April 1995, Week 2
April 1995, Week 1
March 1995, Week 5
March 1995, Week 4
March 1995, Week 3
March 1995, Week 2
March 1995, Week 1
February 1995, Week 4
February 1995, Week 3
February 1995, Week 2
February 1995, Week 1
January 1995, Week 5
January 1995, Week 4
January 1995, Week 3
January 1995, Week 2
January 1995, Week 1
December 1994, Week 5
December 1994, Week 4
December 1994, Week 3
December 1994, Week 2
December 1994, Week 1
November 1994, Week 5
November 1994, Week 4
November 1994, Week 3
November 1994, Week 2
November 1994, Week 1
October 1994, Week 5
October 1994, Week 4
October 1994, Week 3
October 1994, Week 2
October 1994, Week 1
September 1994, Week 5
September 1994, Week 4
September 1994, Week 3
September 1994, Week 2
September 1994, Week 1
August 1994, Week 5
August 1994, Week 4
August 1994, Week 3
August 1994, Week 2
August 1994, Week 1
July 1994, Week 5
July 1994, Week 4
July 1994, Week 3
July 1994, Week 2
July 1994, Week 1
June 1994, Week 5
June 1994, Week 4
June 1994, Week 3
June 1994, Week 2
June 1994, Week 1
May 1994, Week 5
May 1994, Week 4
May 1994, Week 3
May 1994, Week 2
May 1994, Week 1
April 1994, Week 5
April 1994, Week 4
April 1994, Week 3
April 1994, Week 2
April 1994, Week 1
March 1994, Week 5
March 1994, Week 4
March 1994, Week 3
March 1994, Week 2
March 1994, Week 1
February 1994, Week 4
February 1994, Week 3
February 1994, Week 2
February 1994, Week 1
February 1994
January 1994
December 1993
November 1993

ATOM RSS1 RSS2



LISTSERV.UTORONTO.CA

CataList Email List Search Powered by the LISTSERV Email List Manager